Transcriptional mechanisms responsible for the overexpression of the keratin 18 gene in cells of a human colon carcinoma cell line

Experimental Cell Research

Volumn 248, Issue 1, 1999, Pages 243-259

  Prochasson, Philippe ^a   Gunther, Magali ^a   Laithier, Madeleine ^a   Fossar, Nicole ^a   Lavialle, Christian ^a   Brison, Olivier ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Acetylation; Minimal promoter; Spl; Transcription factors

Indexed keywords

HISTONE; HISTONE DEACETYLASE; KERATIN; TRANSCRIPTION FACTOR SP1;

ACETYLATION; ARTICLE; BINDING SITE; CELL CLONE; COLON CARCINOMA; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0033541396     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4402     Document Type: Article

References (47)

1. Fuchs E. Keratins as biochemical markers of epithelial differentiation. Trends Genet. 4:1988;277-281.
2. Moll R. Cytoskeletal markers in the classification of carcinomas and their metastases. Current Communications in Molecular Biology: Cytoskeletal Proteins in Tumor Diagnosis. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 139-144.
3. Oshima R. G., Baribault H., Caulin C. Oncogenic regulation and function of keratins 8 and 18. Cancer Metast. Rev. 15:1996;445-471.
4. Trask D. K., Band V., Zajchoswki D. A., Yasmen P., Suh T., Sager R. Keratins as markers that distinguish normal and tumor derived mammary epithelial cells. Proc. Natl. Acad. Sci. USA. 87:1990;2319-2323.
5. Caulin C., Bauluz C., Gandarillas A., Cano A., Quintanilla M. Changes in keratin expression during malignant progression of transformed mouse epidermal keratinocytes. Exp. Cell Res. 204:1993;11-21.
6. Schaafsma H. E., Ramaekers F. C., van Muijen G. N., Lane E. B., Leigh I. M., Robben H., Huijsmans A., Ooms E. C., Ruiter D. J. Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression. Am. J. Pathol. 136:1990;329-343.
7. Fujisaki J., Shimoda T. Expression of cytokeratin subtypes in colorectal mucosa, adenoma, and carcinoma. Gastroenterol. Jpn. 28:1993;647-656.
8. Zarbo R. J., Gown A. M., Nagle R. B., Visscher D. W., Crissman J. D. Anomalous cytokeratin expression in malignant melanoma: One- and two-dimensional western blot analysis and immunohistochemical survey of 100 melanomas. Mod. Pathol. 3:1990;494-501.
9. Lasota J., Hyjek E., Koo C. H., Blonski J., Miettinen M. Cytokeratin-positive large-cell lymphomas of B-cell lineage: A study of five phenotypically unusual cases verified by polymerase chain reaction. Am. J. Surg. Pathol. 20:1996;346-354.
10. Modjtahedi N., Frebourg T., Fossar N., Lavialle C., Cremisi C., Brison O. Increased expression of cytokeratin and ferritin-H genes in tumorigenic clones of the SW 613-S human colon carcinoma cell line. Exp. Cell Res. 201:1992;74-82.
11. Lavialle C., Modjtahedi N., Cassingena R., Brison O. High c-myc amplification level contributes to the tumorigenic phenotype of the breast carcinoma cell line SW 613-S. Oncogene. 3:1988;335-339.
12. Gunther M., Frebourg T., Laithier M., Fossar N., Bouziane-Ouartini M., Lavialle C., Brison O. An Sp1 binding element and the minimal promoter contribute to the overexpression of the cytokeratin 18 gene in tumorigenic clones relative to that in nontumorigenic clones of a human carcinoma cell line. Mol. Cell. Biol. 15:1995;2490-2499.
13. Modjtahedi N., Lavialle C., Poupon M. F., Landin R. M., Cassingena R., Monier R., Brison O. Increased level of amplification of the c-myc oncogene in tumors induced in nude mice by a human breast carcinoma cell line. Cancer Res. 45:1985;4372-4379.
14. Lavialle C., Modjtahedi N., Cassingena R., Brison O. High c-myc amplification level contributes to the tumorigenic phenotype of the breast carcinoma cell line SW 613-S (correction). Oncogene. 5:1990.
15. Lavialle C., Modjtahedi N., Lamonerie T., Frebourg T., Landin R. M., Fossar N., Lhomond G., Cassingena R., Brison O. The human breast carcinoma cell line SW 613-S: An experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review). Anticancer Res. 9:1989;1265-1280.
16. Nicolas J. F., Berg P. Regulation of expression of genes transduced into embryonal carcinoma cells. Silver L. M., Martin G. R., Strickland S. Cold Spring Harbor Conferences on Cell Proliferation, Vol. 10, Teratocarcinoma Stem Cells. 1983;469-485 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
17. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
18. Shi Y., Seto E., Chang L.-S., Shenk T. Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein. Cell. 67:1991;377-388.
19. Mengus G., May M., Carre L., Chambon P., Davidson I. Human TAF(II)135 potentiates transcriptional activation by the AF-2s of the retinoic acid, vitamin D3, and thyroid hormone receptors in mammalian cells. Genes Dev. 11:1997;1381-1395.
20. Modjtahedi N., Haddada H., Lavialle C., Lazar E., Lamonerie T., Brison O. TGF-alpha production correlates with tumorigenicity in clones of the SW613-S human colon carcinoma cell line. Int. J. Cancer. 52:1992;483-490.
21. Kulesh D. A., Oshima R. G. Complete structure of the gene for human keratin 18. Genomics. 4:1989;339-347.
22. Maldonado E., Ha I., Cortes P., Weis L., Reinberg D. Factors involved in specific transcription by mammalian RNA polymerase II: Role of transcription factors IIA, IID, and IIB during formation of a transcription-competent complex. Mol. Cell. Biol. 10:1990;6335-6347.
23. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
24. Speicher D. W. Protein electroblotting in semidry systems. Coligan J. E., Dunn B. M., Ploegh H. L., Speicher D. W., Wingfield P. T. Current Protocols in Protein Science. 1998;10.7.6-10.7.7 Wiley, New York.
25. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
26. Frebourg T., Brison O. Plasmid vectors with multiple cloning sites and cat-reporter gene for promoter cloning and analysis in animal cells. Gene. 65:1988;315-318.
27. Lang, J. C. Talbot, S. Wilkie, N. M. 1988, pUC vectors capable of conferring neomycin resistance to eukaryotic cells, Nucleic Acids Res. 16, 7736.
28. Dejong J., Roeder R. G. A single cDNA, hTFIIA/alpha, encodes both the p35 and p19 subunits of human TFIIA. Genes Dev. 7:1993;2220-2234.
29. Ozer J., Moore P. A., Bolden A. H., Lee A., Rosen C. A., Lieberman P. M. Molecular cloning of the small(gamma) subunit of human TFIIA reveals functions critical for activated transcription. Genes Dev. 8:1994;2324-2335.
30. Ha I., Lane W. S., Reinberg D. Cloning of a human gene encoding the general transcription initiation factor IIB. Nature. 352:1991;689-695.
31. Peterson M. G., Tanese N., Pugh B. F., Tjian R. Functional domains and upstream activation properties of cloned human TATA binding protein. Science. 248:1990;1625-1630.
32. Chiang C.-M., Roeder R. G. Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators. Science. 267:1995;531-536.
33. Seto E., Lewis B., Shenk T. Interaction between transcription factors Sp1 and YY1. Nature. 365:1993;462-464.
34. Smale S. T., Baltimore D. The "initiator" as a transcription control element. Cell. 57:1989;103-113.
35. Yang H., Melera P. W. Application of the polymerase chain reaction to the ribonuclease protection assay. BioTechniques. 13:1992;922-927.
36. Kulesh D. A., Oshima R. G. Cloning of the human keratin 18 gene and its expression in nonepithelial mouse cells. Mol. Cell. Biol. 8:1988;1540-1550.
37. Bucher P. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J. Mol. Biol. 212:1990;563-578.
38. Smale S. T. Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes. Biochim. Biophys. Acta. 1351:1997;73-88.
39. Reeves R., Gorman C. M., Howard B. Minichromosome assembly of non-integrated plasmid DNA transfected into mammalian cells. Nucleic Acids Res. 13:1985;3599-3615.
40. Oshima R. G., Abrams L., Kulesh D. Activation of an intron enhancer within the keratin 18 gene by expression of c-fos and c-jun in undifferentiated F9 embryonal carcinoma cells. Genes Dev. 4:1990;835-848.
41. Mathis D. J., Oudet P., Wasylyk B., Chambon P. Effect of histone acetylation on structure and in vitro transcription of chromatin. Nucleic Acids Res. 5:1978;3523-3547.
42. Pankov R., Neznanov N., Umezawa A., Oshima R. G. AP-1, ETS, and transcriptional silencers regulate retinoic acid-dependent induction of keratin 18 in embryonic cells. Mol. Cell. Biol. 14:1994;7744-7757.
43. Sealy L., Chalkley R. The effect of sodium butyrate on histone modification. Cell. 14:1978;115-121.
44. Galdemard C., Brison O., Lavialle C. The proto-oncogene FGF-3 is constitutively expressed in tumorigenic, but not in non-tumorigenic, clones of a human colon carcinoma cell line. Oncogene. 10:1995;2331-2342.
45. Lamonerie T., Lavialle C., de Galle B., Binoux M., Brison O. Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line. Exp. Cell Res. 216:1995;342-351.
46. Mizzen C. A., Yang X. J., Kokubo T., Brownell J. E., Bannister A. J., Owen-Hughes T., Workman J., Wang L., Berger S. L., Kouzarides T., Nakatani Y., Allis C. D. The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell. 87:1996;1261-1270.
47. Pankov R., Umezawa A., Maki R., Der C. J., Hauser C. A., Oshima R. G. Oncogene activation of human keratin 18 transcription via the Ras signal transduction pathway. Proc. Natl. Acad. Sci. USA. 91:1994;873-877.